Tesaro (TSRO) PT Raised to $72 at Deutsche Bank Following Deal with Anaptysbio
Tweet
Share
E-mailGet Alerts TSRO Hot Sheet
Price: $74.96 --0%
Rating Summary:
7 Buy, 18 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 17
Rating Summary:
7 Buy, 18 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 17
Join SI Premium – FREE
Deutsche Bank a Buy rating on Tesaro (NASDAQ: TSRO) and raised its price target to $72.00 (from $62.00). The change follows news of a deal with Anaptysbio.
"We see today’s deal with Anaptysbio as value creating and in our view, this reiterates management expertise in the cancer space," said analyst Robyn Karnauskas. "We note that it is along the lines of how big-pharma is thinking about the evolution of the immunotherapy space in cancer. TSRO has in-licensed 5 antibodies: PD1, TIM-3, LAG-3, & 2 bi-specifics. These drugs would start to move into the clinics in 2015 & combo of PD1 with ALK/PARP will also be evaluated. We value immunotherapy platform at ~$10/sh to DCF at 25% probability."
For an analyst ratings summary and ratings history on Tesaro click here. For more ratings news on Tesaro click here.
Shares of Tesaro closed at $30.48 yesterday.
"We see today’s deal with Anaptysbio as value creating and in our view, this reiterates management expertise in the cancer space," said analyst Robyn Karnauskas. "We note that it is along the lines of how big-pharma is thinking about the evolution of the immunotherapy space in cancer. TSRO has in-licensed 5 antibodies: PD1, TIM-3, LAG-3, & 2 bi-specifics. These drugs would start to move into the clinics in 2015 & combo of PD1 with ALK/PARP will also be evaluated. We value immunotherapy platform at ~$10/sh to DCF at 25% probability."
For an analyst ratings summary and ratings history on Tesaro click here. For more ratings news on Tesaro click here.
Shares of Tesaro closed at $30.48 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- QuantumScape (QS) PT Lowered to $6 at Truist Securities
- Canfor Pulp Products (CFX:CN) (CFPUF) PT Raised to Cdn$2.75 at Raymond James
- London Stock Exchange Group Plc. (LSEG:LN) (LNSTY) PT Raised to GBP88 at HSBC
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS View, Analyst PT ChangeRelated Entities
Deutsche BankSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
